EMMAUS LIFE SCIENCES, INC. Operating Lease Right-of-Use Assets
EMMAUS LIFE SCIENCES, INC. (EMMA) had Operating Lease Right-of-Use Assets of $808.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-14
- 2026-06-30: Operating Lease, Right-of-Use Asset $808.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $736.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $766.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $799.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $808.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $736.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $766.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $799.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $830.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.33M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.53M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.72M 10-Q · filed 2024-11-19 |
| 2024-06-30 | $1.90M 10-Q · filed 2024-09-10 |
| 2024-03-31 | $2.08M 10-Q · filed 2024-09-10 |
| 2023-12-31 | $2.34M 10-K · filed 2025-04-14 |
| 2023-09-30 | $2.51M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.58M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.65M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.80M 10-K · filed 2024-07-03 |
| 2022-09-30 | $2.94M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.08M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $3.32M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $3.48M 10-K · filed 2023-03-31 |
| 2021-09-30 | $3.64M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $3.80M 10-Q · filed 2021-09-01 |
| 2021-03-31 | $3.95M 10-Q · filed 2021-09-01 |
| 2020-12-31 | $4.07M 10-K · filed 2022-03-31 |
| 2020-09-30 | $4.14M 10-Q · filed 2021-08-26 |
| 2020-06-30 | $4.28M 10-Q · filed 2021-08-26 |
| 2020-03-31 | $4.34M 10-Q · filed 2021-08-26 |
| 2019-12-31 | $4.47M 10-Q · filed 2021-08-26 |
| 2019-09-30 | $4.12M 10-K · filed 2021-01-25 |
| 2019-06-30 | $4.29M 10-Q · filed 2021-08-26 |
| 2019-03-31 | $2.84M 10-Q · filed 2021-08-26 |